Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Cardio

Date Submitted: Nov 29, 2023
Open Peer Review Period: Nov 29, 2023 - Jan 24, 2024
Date Accepted: Mar 22, 2024
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Identifying Predictors of Heart Failure Readmission in Patients From a Statutory Health Insurance Database: Retrospective Machine Learning Study

Levinson R, Paul C, Meid A, Schultz JH, Wild B

Identifying Predictors of Heart Failure Readmission in Patients From a Statutory Health Insurance Database: Retrospective Machine Learning Study

JMIR Cardio 2024;8:e54994

DOI: 10.2196/54994

PMID: 39042456

PMCID: 11318205

Identifying predictors of heart failure readmission in patients from a statutory health insurance database: Retrospective machine learning study

  • Rebecca Levinson; 
  • Cinara Paul; 
  • Andreas Meid; 
  • Jobst-Hendrik Schultz; 
  • Beate Wild

ABSTRACT

Background:

Heart failure (HF) patients are the most commonly readmitted group of adult patients in Germany. Most HF patients are readmitted for non-cardiovascular reasons. Understanding the relevance of HF management outside the hospital setting is critical to understanding HF and factors that lead to readmission. Application of machine learning (ML) on data from statutory health insurance (SHI) allows evaluation of large longitudinal datasets representative of the general population in order to support clinical decision making.

Objective:

To evaluate the ability of machine learning methods to predict HF readmission in outpatient data and identify important predictors

Methods:

Using six years of outpatient data from the AOK Baden-Württemberg SHI in Germany, we applied a machine learning approach to predict 1-year all-cause and HF-specific readmission after the first admission for HF. We fitted a random forest, an elastic net, a stepwise regression, and a logistic regression to use diagnosis codes, drug exposures, and demographics to predict readmission.

Results:

Our final dataset consisted of 97,529 individuals, 78044 (80%) of whom were readmitted within the observation period. The random forest approach best predicted all-cause and HF specific readmission with a C-statistic of 0.68 and 0.69, respectively. Important predictors for all-cause readmission included prescription of pantoprazole, chronic obstructive pulmonary disease, atherosclerosis, sex, rurality, and participation in disease management programs for type 2 diabetes mellitus and coronary heart disease.

Conclusions:

While many of the predictors we identified were known to be relevant comorbidities for HF, we also uncovered several novel associations. Disease management programs have widely been shown to be effective at managing chronic disease, however, our results indicate that in the short term they may be useful for targeting HF patients with comorbidity at increased risk of readmission. Our results also show that living in a more rural location increases risk of readmission. Overall, factors beyond comorbid disease were relevant for risk of HF readmission. This finding may impact how outpatient physicians identify and monitor patients at risk of HF readmission.


 Citation

Please cite as:

Levinson R, Paul C, Meid A, Schultz JH, Wild B

Identifying Predictors of Heart Failure Readmission in Patients From a Statutory Health Insurance Database: Retrospective Machine Learning Study

JMIR Cardio 2024;8:e54994

DOI: 10.2196/54994

PMID: 39042456

PMCID: 11318205

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.